PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-12450.00%
Both yoy net incomes decline, with CRK at -250.23%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-19.59%
Both reduce yoy D&A, with CRK at -100.00%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-402.38%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
66.08%
Slight usage while CRK is negative at -181.33%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
66.08%
Some yoy usage while CRK is negative at -31382.91%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-57.89%
Negative yoy while CRK is 359.45%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
2.27%
Some CFO growth while CRK is negative at -93.45%. John Neff would note a short-term liquidity lead over the competitor.
28.84%
CapEx growth well above CRK's 10.82%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-99.66%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-304.27%
We reduce yoy other investing while CRK is 287.41%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-160.74%
We reduce yoy invests while CRK stands at 87.61%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.